Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Mill

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|October 20, 2007
Inter-conversion of neuregulin2 full and partial agonists for ErbB4Kristy J Wilson, Christopher P Mill, Elizabeth M Cameron, et al.
The Biochemical Journal|January 6, 2012
The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonistKristy J Wilson, Christopher P Mill, Richard M Gallo, et al.
Biochemistry|July 6, 2006
Biochemical and structural studies of N5-carboxyaminoimidazole ribonucleotide mutase from the acidophilic bacterium Acetobacter acetiCharles Z Constantine, Courtney M Starks, Christopher P Mill, et al.
Genome Announcements|June 7, 2014
Draft Genome Sequence of Acetobacter aceti Strain 1023, a Vinegar Factory IsolateJohn E Hung, Christopher P Mill, Sandra W Clifton, et al.
Cancer Research|August 10, 2016
SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing AgentsWarren Fiskus, Veena Coothankandaswamy, Jianguang Chen, et al.
Leukemia|September 29, 2016
BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cellsDyana T Saenz, Warren Fiskus, Taghi Manshouri, et al.
Blood Cancer Journal|February 5, 2024
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)Christopher P Mill, Warren C Fiskus, Courtney D DiNardo, et al.
Leukemia|March 28, 2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1Christopher P Mill, Warren Fiskus, Kaberi Das, et al.
Molecular Cell|March 3, 2018
Dynamic Regulation of Long-Chain Fatty Acid Oxidation by a Noncanonical Interaction between the MCL-1 BH3 Helix and VLCADSilvia Escudero, Elma Zaganjor, Susan Lee, et al.
Leukemia|December 19, 2025
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AMLChristine E Birdwell, Warren Fiskus, Christopher P Mill, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|October 20, 2007
Inter-conversion of neuregulin2 full and partial agonists for ErbB4Kristy J Wilson, Christopher P Mill, Elizabeth M Cameron, et al.
The Biochemical Journal|January 6, 2012
The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonistKristy J Wilson, Christopher P Mill, Richard M Gallo, et al.
Biochemistry|July 6, 2006
Biochemical and structural studies of N5-carboxyaminoimidazole ribonucleotide mutase from the acidophilic bacterium Acetobacter acetiCharles Z Constantine, Courtney M Starks, Christopher P Mill, et al.
Genome Announcements|June 7, 2014
Draft Genome Sequence of Acetobacter aceti Strain 1023, a Vinegar Factory IsolateJohn E Hung, Christopher P Mill, Sandra W Clifton, et al.
Cancer Research|August 10, 2016
SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing AgentsWarren Fiskus, Veena Coothankandaswamy, Jianguang Chen, et al.
Leukemia|September 29, 2016
BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cellsDyana T Saenz, Warren Fiskus, Taghi Manshouri, et al.
Blood Cancer Journal|February 5, 2024
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)Christopher P Mill, Warren C Fiskus, Courtney D DiNardo, et al.
Leukemia|March 28, 2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1Christopher P Mill, Warren Fiskus, Kaberi Das, et al.
Molecular Cell|March 3, 2018
Dynamic Regulation of Long-Chain Fatty Acid Oxidation by a Noncanonical Interaction between the MCL-1 BH3 Helix and VLCADSilvia Escudero, Elma Zaganjor, Susan Lee, et al.
Leukemia|December 19, 2025
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AMLChristine E Birdwell, Warren Fiskus, Christopher P Mill, et al.
Pageof 4